Intrathecal drug delivery 2002

  • Michael S. TurnerEmail author
Conference paper
Part of the Acta Neurochirurgica Supplements book series (NEUROCHIRURGICA, volume 87)



Intrathecal drug delivery has been used clinically since the 1970’s. Significant clinical advances have been made combining new technology with pharmacology and surgery. Continuous infusion of medication for both analgesia and spasticity has become a part of the armamentarium for specialists in these areas. Significant recent advances in technology promise further enhancements and improvements for intrathecal therapy.


A review of the literature combined with 20 years personal experience with intrathecal drug delivery.


Intrathecal therapy has established a role in the treatment of malignant pain, benign pain and severe spasticity. Significant literature and the current state of practice in the United States are reviewed. Recent therapeutic enhancements are discussed, and a wish list of future technological enhancements presented.


Intrathecal baclofen morphine infusion pump 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Albright AL (1996) Intrathecal baclofen in cerebral palsy movement disorders. J Child Neurol [Suppl] 1: S29–35Google Scholar
  2. 2.
    Albright AL (1996) Baclofen in the treatment of cerebral palsy. J Child Neurol 11(2): 77–83PubMedCrossRefGoogle Scholar
  3. 3.
    Albright AL, Barron WB, Fasick MP, Polinko P, Janosky J (1993) Continuous intrathecal baclofen infusion for spasticity of cerebral origin. JAMA 270(20): 2475–2477PubMedCrossRefGoogle Scholar
  4. 4.
    Albright AL, Barry MJ, Fasick P, Barron W, Shultz B (1996) Continuous intrathecal baclofen infusion for symptomatic generalized dystonia. Neurosurgery 38(5): 934–938PubMedCrossRefGoogle Scholar
  5. 5.
    Albright AL, Barry MJ, Shafton DH, Ferson SS (2001) Intrathecal baclofen for generalized dystonia. Dev Med Child Neurol 43(10): 652–657PubMedCrossRefGoogle Scholar
  6. 6.
    Armstrong RW, Steinbok P, Cochrane DD, Kube SD, Fife SE, Farrell K (1997) Intrathecally administered baclofen for treatment of children with spasticity of cerebral origin. Intensive Care Med 23(8): 896–9023CrossRefGoogle Scholar
  7. 7.
    Atweh SF, Kuhar MJ (1977) Autoradiographic localization of opiate receptors in rat brain. I. Spinal cord and lower medulla. Brain Res 124: 53PubMedCrossRefGoogle Scholar
  8. 8.
    Ault B, Evans R (1981) The depressant effect of baclofen on the isolated spinal cord of the neonatal rat. Eur J Pharmacol 71: 357–364PubMedCrossRefGoogle Scholar
  9. 9.
    Azouvi P, Mane M, Thiebaut JB, Denys P, Remy-Neris O, Bussel B (1996) Intrathecal baclofen administration for control of severe spinal spasticity: functional improvement and longterm follow-up. Arch Phys Med Rehabil 77(1): 35–39PubMedCrossRefGoogle Scholar
  10. 10.
    Becker R, Benes L, Sure U, Hellwig D, Bertalanffy H (2000) Intrathecal baclofen alleviates autonomic dysfunction in severe brain injury. J Clin Neurosci 7(4): 316–319PubMedCrossRefGoogle Scholar
  11. 11.
    Belfrage M, Segerdahl M, Arner S, Sollevi A (1999) The safety and efficacy of intrathecal adenosine in patients with chronic neuropathic pain. Anesth Analg 89(1): 136–142PubMedGoogle Scholar
  12. 12.
    Bennett G, Deer T, Du Pen S, Rauck R, Yaksh T, Hassenbusch SJ (2000) Future directions in the management of pain by intraspinal drug delivery. J Pain Symptom Manage 20(2): S44–50PubMedCrossRefGoogle Scholar
  13. 13.
    Bennett G, Serafini M, Burchiel K, Buchser E, Classen A, Deer T, Du Pen S, Ferrante FM, Hassenbusch SJ, Lou L, Maeyaert J, Penn R, Portenoy RK, Rauck R, Willis KD, Yaksh T (2000) Evidence-based review of the literature on intrathecal delivery of pain medication. J Pain Symptom Manage 20(2): S12–36PubMedCrossRefGoogle Scholar
  14. 14.
    Boots RJ, Lipman J, O’Callaghan J, Scott P, Fraser J (2000) The treatment of tetanus with intrathecal baclofen. Anaesth Intensive Care 28(4): 438–442PubMedGoogle Scholar
  15. 15.
    Buchheit T, Rauck R (1999) Subarachnoid techniques for cancer pain therapy: when, why, and how? Curr Rev Pain 3(3): 198–205PubMedCrossRefGoogle Scholar
  16. 16.
    Butler C, Campbell S (2000) Evidence of the effects of intrathecal baclofen for spastic and dystonic cerebral palsy. AACPDM Treatment Outcomes Committee Review Panel. Dev Med Child Neurol 42(9): 634–645PubMedCrossRefGoogle Scholar
  17. 17.
    Coffey RJ, Burchiel K (2002) Inflammatory mass lesions associated with intrathecal drug infusion catheters: Report and observations on 41 patients. Neurosurgery 50(1): 78–86PubMedGoogle Scholar
  18. 18.
    Coffey JR, Cahill D, Steers W, Park TS, Ordia J, Meythaler J, Herman R, Shetter AG, Levy R, Gill B et al (1993) Intrathecal baclofen for intractable spasticity of spinal origin: results of a long-term multicenter study. J Neurosurg 78(2): 226–232PubMedCrossRefGoogle Scholar
  19. 19.
    Cuny E, Richer E, Castel JP (2001) Dysautonomia syndrome in the acute recovery phase after traumatic brain injury: Relief with intrathecal Baclofen therapy. Brain Inj 15(10): 917–925PubMedCrossRefGoogle Scholar
  20. 20.
    Davis R (1975) Spasticity following spinal cord injury. Clin Orthop 112: 66–75PubMedGoogle Scholar
  21. 21.
    Dressnandt J, Konstanzer A, Weinzierl FX, Pfab R, Klingelhofer J (1997) Intrathecal baclofen in tetanus: four cases and a review of reported cases. J Neurosurg 87(3): 409–410CrossRefGoogle Scholar
  22. 22.
    Fanciullo GJ, Rose RJ, Lunt PG, Whalen PK, Ross E (1999) The state of implantable pain therapies in the United States: a nationwide survey of academic teaching programs. Anesth Analg 88(6): 1311–1316PubMedGoogle Scholar
  23. 23.
    Follett KA, Naumann CP (2000) A prospective study of catheter-related complications of intrathecal drug delivery systems. J Pain Symptom Manage 19(3): 209–215PubMedCrossRefGoogle Scholar
  24. 24.
    Ford B, Greene P, Louis ED, Petzinger G, Bressman SB, Goodman R, Brin MF, Sadiq S, Fahn S (1996) Use of intrathecal baclofen in the treatment of patients with dystonia. Arch Neurol 53(12): 1241–1246PubMedCrossRefGoogle Scholar
  25. 25.
    Francois B, Vacher P, Roustan J, Salle JY, Vidal J, Moreau J J, Vignon P (2001) Intrathecal baclofen after traumatic brain injury: early treatment using a new technique to prevent spasticity. J Trauma 50(1): 158–161PubMedCrossRefGoogle Scholar
  26. 26.
    Gatscher S, Becker R, Uhle E, Bertalanffy H (2002) Combined intrathecal baclofen and morphine infusion for the treatment of spasticity related pain and central deafferentiation pain. Acta Neurochir (Wien) [Suppl] 79: 75–76Google Scholar
  27. 27.
    Gormley Jr ME, Krach LE, Piccini L (2001) Spasticity management in the child with spastic quadriplegia. Eur J Neurol [Suppl] 5: 127–135CrossRefGoogle Scholar
  28. 28.
    Grabb PA, Guin-Renfroe S, Meythaler JM (1999) Midthoracic catheter tip placement for intrathecal baclofen administration in children with quadriparetic spasticity. Neurosurgery 45(4): 833–836PubMedCrossRefGoogle Scholar
  29. 29.
    Grabow TS, Derdzinski D, Staats PS (2001) Spinal drug delivery. Curr Pain Headache Rep 5(6): 510–516PubMedCrossRefGoogle Scholar
  30. 30.
    Greene PE, Fahn S (1992) Baclofen in the treatment of idiopathic dystonia in children. Mov Disord 7(1): 48–52PubMedCrossRefGoogle Scholar
  31. 31.
    Halter JA, Blight AR, Donovan WH, Calvillo O (2000) Intrathecal administration of 4-aminopyridine in chronic spinal injured patients. Spinal Cord 38(12): 728–732PubMedCrossRefGoogle Scholar
  32. 32.
    Hugenholtz H, Nelson RF, Dehoux E (1993) Intrathecal baclofen — the importance of catheter position. Can J Neurol Sci 20(2): 165–167PubMedGoogle Scholar
  33. 33.
    Ivanhoe CB, Tilton AH, Francisco GE (2001) Intrathecal baclofen therapy for spastic hypertonia. Phys Med Rehabil Clin N Am 12(4): 923–938, viii–ixPubMedGoogle Scholar
  34. 34.
    Jain K. K. (2000) An evaluation of intrathecal ziconotide for the treatment of chronic pain. Expert Opin Investig Drugs 9(10): 2403–2410PubMedCrossRefGoogle Scholar
  35. 35.
    Kerr JZ, Berg S, Blaney SM (2001) Intrathecal chemotherapy. Crit Rev Oncol Hematol 37(3): 227–236PubMedCrossRefGoogle Scholar
  36. 36.
    Kopell BH, Sala D, Doyle WK, Feldman DS, WisofT JH, Weiner HL (2001) Subfascial implantation of intrathecal baclofen pumps in children: technical note. Neurosurgery 49(3): 753–756; discussion 756–757PubMedGoogle Scholar
  37. 37.
    Krames ES (1999) Practical issues when using neuraxial infusion. Oncology (Huntingt) 13(5) [Suppl] 2: 37–44PubMedGoogle Scholar
  38. 38.
    Kroin JS, Ali A, York M, Penn RD (1993) The distribution of medication along the spinal canal after chronic intrathecal administration. Neurosurgery 33(2): 226–230PubMedCrossRefGoogle Scholar
  39. 39.
    Kumar K, Kelly M, Pirlot T (2001) Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy. Surg Neurol 55(2): 79–86PubMedCrossRefGoogle Scholar
  40. 40.
    Langsam A (1999) A case of spinal cord compression syndrome by a fibrotic mass presenting in a patient with an intrathecal pain management pump system. Pain 83(1): 97–99PubMedCrossRefGoogle Scholar
  41. 41.
    Levin AB, Sperling KB, Penn RD, Gianino JM, York MM (1995) Complications associated with infusion pumps implanted for spasticity. Stereotact Funct Neurosurg 65(1–4): 147–151PubMedCrossRefGoogle Scholar
  42. 42.
    Meythaler JM, DeVivo MJ, Hadley M (1996) Prospective study on the use of bolus intrathecal baclofen for spastichypertonia due to acquired brain injury. Arch Phys Med Rehabil 77(5): 461–466PubMedCrossRefGoogle Scholar
  43. 43.
    Meythaler JM, Guin-Renfroe S, Brunner RC, Hadley MN (2001) Intrathecal baclofen for spastic hypertonia from stroke. Stroke 32(9): 2099–2109PubMedCrossRefGoogle Scholar
  44. 44.
    Meythaler JM, Guin-Renfroe S, Grabb P, Hadley MN (1999) Long-term continuously infused intrathecal baclofen for spasticdystonic hypertonia in traumatic brain injury: 1-year experience. Arch Phys Med Rehabil 80(1): 13–19PubMedCrossRefGoogle Scholar
  45. 45.
    Meythaler JM, Guin-Renfroe S, Hadley MN (1999) Continuously infused intrathecal baclofen for spastic/dystonic hemiplegia: a preliminary report. Am J Phys Med Rehabil 78(3): 247–254PubMedCrossRefGoogle Scholar
  46. 46.
    Meythaler JM, Steers WD, Tuel SM, Cross LL, Haworth CS (1992) Continuous intrathecal baclofen in spinal cord spasticity. A prospective study. Am J Phys Med Rehabil 71(6): 321–327PubMedCrossRefGoogle Scholar
  47. 47.
    Middel B, Kuipers-Upmeijer H, Bouma J, Staal M, Oenema D, Postma T, Terpstra S, Stewart R (1997) Effect of intrathecal baclofen delivered by an implanted programmable pump on health related quality of life in patients with severe spasticity. J Neurol Neurosurg Psychiatry 63(2): 204–294PubMedCrossRefGoogle Scholar
  48. 48.
    Middleton JW, Siddall PJ, Walker S, Molloy AR, Rutkowski SB (1996) Intrathecal clonidine and baclofen in the management of spasticity and neuropathic pain following spinal cord injury: a case study. Arch Neurol 53(12): 1241–1246CrossRefGoogle Scholar
  49. 49.
    Ochs G, Penn RD, York M, Giess R, Beck M, Tonn J, Haigh J, Malta E, Traub M, Sendtner M, Toyka KV (2000) A phase I/II trial of recombinant methionyl human brain derived neurotrophic factor administered by intrathecal infusion to patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord 1(3): 201–206PubMedCrossRefGoogle Scholar
  50. 50.
    Osenbach RK, Harvey S (2001) Neuraxial infusion in patients with chronic intractable cancer and noncancer pain. Curr Pain Headache Rep 5(3): 241–249PubMedCrossRefGoogle Scholar
  51. 51.
    Paice JA, Penn RD, Kroin JS (1996) Intrathecal octreotide for relief of intractable nonmalignant pain: 5-year experience with two cases. Neurosurgery 38(1): 203–207PubMedCrossRefGoogle Scholar
  52. 52.
    Paret G, Tirosh R, Ben Zeev B, Vardi A, Brandt N, Barzilay Z (1996) Intrathecal baclofen for severe torsion dystonia in a child. Acta Paediatr 85(5): 635–637PubMedCrossRefGoogle Scholar
  53. 53.
    Penn RD (1988) Intrathecal baclofen for severe spasticity. Ann N Y Acad Sci 531: 157–166PubMedCrossRefGoogle Scholar
  54. 54.
    Penn RD (1992) Intrathecal baclofen for spasticity of spinal origin: seven years of experience. J Neurosurg 77(2): 236–240PubMedCrossRefGoogle Scholar
  55. 55.
    Penn RD, Kroin JS (1984) Intrathecal baclofen alleviates spinal cord spasticity. Lancet 1(8385): 1078PubMedCrossRefGoogle Scholar
  56. 56.
    Penn RD, Paice JA (2000) Adverse effects associated with the intrathecal administration of ziconotide. Pain 85(1–2): 291–296PubMedCrossRefGoogle Scholar
  57. 57.
    Penn RD, Savoy SM, Corcos D, Latash M, Gottlieb G, Parke B, Kroin JS (1989) Intrathecal baclofen for severe spinal spasticity. N Engl J Med 320(23): 1517–1521PubMedCrossRefGoogle Scholar
  58. 58.
    Pert CB, Snyder SH (1973) Opiate receptor: demonstration in nervous tissue. Science 179: 1011PubMedCrossRefGoogle Scholar
  59. 59.
    Price GW, Wilkin GP, Turnbull MJ, Bowery N G (1984) Are Baclofen sensitive GABA-B receptors present on primary afferent terminals of the spinal cord? Nature Jan 307(5946): 71–74CrossRefGoogle Scholar
  60. 60.
    Rainov NG, Heidecke V, Burkert W (2001) Long-term intrathecal infusion of drug combinations for chronic back and leg pain. J Pain Symptom Manage 22(4): 862–871PubMedCrossRefGoogle Scholar
  61. 61.
    Rifici C, Kofler M, Kronenberg M, Kofler A, Bramanti P, Saltuari L (1994) Intrathecal baclofen application in patients with supraspinal spasticity secondary to severe traumatic brain injury. Funct Neurol 9(1): 29–34PubMedGoogle Scholar
  62. 62.
    Saissy JM, Demaziere J, Vitris M, Seek M, Marcoux L, Gaye M, Ndiaye M (1992) Treatment of severe tetanus by intrathecal injections of baclofen without artificial ventilation. Intensive Care Med 18(4): 241–244PubMedCrossRefGoogle Scholar
  63. 63.
    Sampson FC, Hayward A, Evans G, Morton R, Collett B (2002) Functional benefits and cost/benefit analysis of continuous intrathecal baclofen infusion for the management of severe spasticity. J Neurosurg 96(6): 1052–1057PubMedCrossRefGoogle Scholar
  64. 64.
    Sator-Katzenschlager S, Deusch E, Maier P, Spacek A, Kress HG (2001) The long-term antinociceptive effect of intrathecal S(+)-ketamine in a patient with established morphine tolerance. Anesth Analg 93(4): 1032–1034PubMedCrossRefGoogle Scholar
  65. 65.
    Taira T, Kawamura H, Tanikawa T, Kawabatake H, Iseki H, Ueda A, Takakura K (1995) A new approach to the control of central deafferentation pains — pinal intrathecal baclofen. Acta Neurochir (Wien) [Suppl] 64: 136–138CrossRefGoogle Scholar
  66. 66.
    Thomas JE, Rosenwasser RH, Armonda RA, Harrop J, Mitchell W, Galaria I (1999) Safety of intrathecal sodium nitroprusside for the treatment and prevention of refractory cerebral vasospasm and ischemia in humans. Stroke 30(7): 1409–1416PubMedCrossRefGoogle Scholar
  67. 67.
    van Hilten BJ, van de Beek WJ, HofT JI, Voormolen JH, Delhaas EM (2000) Intrathecal baclofen for the treatment of dystonia in patients with reflex sympathetic dystrophy. N Engl J Med 343(9): 625–630PubMedCrossRefGoogle Scholar
  68. 68.
    Van Schaeybroeck P, Nuttin B, Lagae L, Schrijvers E, Borghgraef C, Feys (2000) Intrathecal baclofen for intractable cerebral spasticity: a prospective placebo-controlled, double-blind study. Neurosurgery 46(3)Google Scholar
  69. 69.
    Walker RH, Danisi FO, Swope DM, Goodman RR, Germano IM, Brin MF (2000) Intrathecal baclofen for dystonia: benefits and complications during six years of experience. Mov Disord 15(6): 1242–1247PubMedCrossRefGoogle Scholar
  70. 70.
    Wang JK, Nauss LA, Thomas JE (1979) Pain relief by intrathecally applied morphine in man. Anesthesiology 50(2): 149–151PubMedCrossRefGoogle Scholar
  71. 71.
    Zuniga RE, Perera S, Abram SE (2002) Intrathecal baclofen: a useful agent in the treatment of well-established complex regional pain syndrome. Reg Anesth Pain Med 27(1): 90–93PubMedGoogle Scholar
  72. 72.
    Zuniga RE, Schlicht CR, Abram SE (2000) Intrathecal baclofen is analgesic in patients with chronic pain. Anesthesiology 92(3): 876–880PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Wien 2003

Authors and Affiliations

  1. 1.Pediatric NeurosurgeryIndianapolis Neurosurgical Group, Inc.USA

Personalised recommendations